N18.5

Chronic kidney disease, stage 5

Chronic kidney disease (CKD) stage 5, also known as end-stage renal disease (ESRD), represents the most advanced and severe form of kidney failure. It is characterized by a glomerular filtration rate (GFR) of less than 15 mL/min/1.73 m² or kidney failure requiring dialysis or transplantation. At this stage, the kidneys have lost almost all their ability to function, leading to a profound accumulation of waste products, fluid imbalances, and severe metabolic and hormonal disturbances throughout the body. Without renal replacement therapy (dialysis or kidney transplant), CKD stage 5 is life-threatening. ## Pathophysiology CKD stage 5 is the culmination of progressive, irreversible damage to the nephrons, the functional units of the kidney. Regardless of the underlying etiology (e.g., diabetes, hypertension, glomerulonephritis), the common pathway involves a reduction in the total number of functioning nephrons. As nephrons are destroyed, the remaining healthy nephrons undergo compensatory hypertrophy and hyperfiltration to maintain kidney function. However, this compensatory mechanism is ultimately deleterious, leading to further injury and scarring (glomerulosclerosis and tubulointerstitial fibrosis). This vicious cycle results in a relentless decline in GFR. With a GFR below 15 mL/min/1.73 m², the kidneys can no longer adequately excrete nitrogenous wastes (urea, creatinine), regulate fluid and electrolyte balance (sodium, potassium, calcium, phosphate), produce hormones (erythropoietin, active vitamin D), or metabolize drugs. The accumulation of uremic toxins contributes to systemic inflammation and oxidative stress, affecting nearly every organ system. Key pathophysiological consequences include: severe fluid overload, hyperkalemia, metabolic acidosis, hypocalcemia, hyperphosphatemia, secondary hyperparathyroidism, anemia due to erythropoietin deficiency, cardiovascular disease (uremic cardiomyopathy, accelerated atherosclerosis), and peripheral and central nervous system dysfunction. ## Clinical Presentation The clinical presentation of CKD stage 5 is dominated by symptoms of uremia and the complications arising from severe kidney dysfunction. Many patients may have been asymptomatic or mildly symptomatic in earlier stages, but at stage 5, symptoms are typically pronounced and significantly impact quality of life. Common signs and symptoms include: ### General Symptoms * **Fatigue and weakness:** Profound and persistent, often due to anemia, uremic toxins, and poor nutrition. * **Loss of appetite, nausea, vomiting:** Common gastrointestinal manifestations of uremia. * **Unintended weight loss:** Due to anorexia, catabolism, and malabsorption. * **Generalized pruritus (itching):** A distressing symptom, likely due to accumulation of uremic toxins and secondary hyperparathyroidism. ### Fluid and Electrolyte Imbalances * **Edema:** Swelling in the legs, ankles, and around the eyes, due to fluid retention. May progress to pulmonary edema, causing shortness of breath. * **Shortness of breath (dyspnea):** Can be due to fluid overload, anemia, or metabolic acidosis. * **Hypertension:** Often severe and difficult to control. ### Neurological Symptoms * **Muscle cramps and weakness:** Due to electrolyte imbalances. * **Restless legs syndrome:** Common and disruptive to sleep. * **Neuropathy:** Peripheral neuropathy (numbness, tingling, pain in extremities) and autonomic dysfunction. * **Uremic encephalopathy:** In severe cases, leading to confusion, lethargy, seizures, and coma. ### Hematological and Endocrine Issues * **Anemia:** Pallor, fatigue, exercise intolerance due to erythropoietin deficiency and iron malabsorption. * **Renal bone disease (osteodystrophy):** Bone pain, increased fracture risk, due to disturbed calcium-phosphate metabolism and secondary hyperparathyroidism. * **Skin changes:** Pallor, yellowish-brown discoloration,

Clinical Symptoms

  • Profound fatigue and weakness
  • Loss of appetite (anorexia)
  • Nausea and vomiting
  • Generalized pruritus (itching)
  • Edema (swelling of legs, ankles, face)
  • Shortness of breath (dyspnea), especially on exertion or when lying flat
  • Uncontrolled hypertension
  • Muscle cramps
  • Restless legs syndrome
  • Peripheral neuropathy (numbness, tingling, pain in extremities)
  • Uremic encephalopathy (confusion, lethargy, impaired concentration, seizures)
  • Metallic taste in mouth
  • Easy bruising or bleeding tendency
  • Pallor (pale skin) due to anemia
  • Yellowish-brown skin discoloration
  • Bone pain and increased fracture risk
  • Sexual dysfunction
  • Sleep disturbances
  • Pericarditis (inflammation of the heart lining)
  • Pleural effusion (fluid around the lungs)

Common Causes

  • Diabetes mellitus (Type 1 and Type 2) - most common cause
  • Hypertension (long-standing and uncontrolled)
  • Glomerulonephritis (inflammation of the kidney's filtering units)
  • Polycystic kidney disease (PKD)
  • Other inherited kidney diseases
  • Obstructive nephropathy (e.g., kidney stones, enlarged prostate, tumors blocking urine flow)
  • Recurrent pyelonephritis (kidney infections)
  • Autoimmune diseases (e.g., lupus nephritis, vasculitis)
  • Drug-induced kidney injury (e.g., prolonged use of NSAIDs, certain antibiotics)
  • Atherosclerotic renovascular disease (narrowing of renal arteries)
  • Reflux nephropathy
  • Alport syndrome
  • HIV-associated nephropathy
  • Amyloidosis
  • Sickle cell nephropathy

Documentation & Coding Tips

Document the specific stage of Chronic Kidney Disease (CKD) clearly, especially Stage 5 (N18.5), and if it is dependent on dialysis (N18.6).

Example: Patient is a 72 y/o male with known Chronic Kidney Disease, Stage 5 (N18.5), currently managed with hemodialysis three times per week. He presents today with increasing fatigue and lower extremity edema, likely related to fluid overload between dialysis sessions. Assessment: CKD Stage 5 on hemodialysis (N18.6); fluid overload. Plan: Adjust dry weight target, continue hemodialysis, monitor electrolytes. This is an established patient with high complexity due to multiple chronic conditions and end-organ failure.

Billing Focus: Specifying 'Stage 5' provides high specificity. Adding 'on hemodialysis' (N18.6) indicates End-Stage Renal Disease (ESRD), allowing for appropriate billing of ESRD-related services. The complexity of managing fluid overload in the context of ESRD supports higher E/M coding.

Always document the underlying etiology of CKD Stage 5 when known, such as diabetic nephropathy or hypertensive nephropathy, and any associated complications.

Example: Patient is a 68 y/o female with Type 2 Diabetes Mellitus with diabetic nephropathy (E11.22) as the etiology of her Chronic Kidney Disease, Stage 5 (N18.5), not yet on dialysis. She also has uncontrolled essential hypertension (I10) and presents with acute exacerbation of heart failure (I50.9) due to fluid retention secondary to advanced CKD. Assessment: CKD Stage 5 (N18.5) due to Type 2 DM with diabetic nephropathy (E11.22); uncontrolled essential hypertension (I10); acute exacerbation of heart failure (I50.9). Plan: Aggressive diuresis, dietary sodium restriction, close monitoring of renal function, discussion of renal replacement therapy options.

Billing Focus: Documenting the etiology (E11.22 for diabetic nephropathy) and complications (I50.9 for heart failure) provides a complete clinical picture and supports medical necessity for services. This detail is crucial for E/M complexity and justification of advanced care.

Detail all current management strategies for CKD Stage 5, including type of renal replacement therapy (RRT) if applicable, and management of related symptoms/complications.

Example: Patient is a 55 y/o male with End-Stage Renal Disease (N18.6) secondary to polycystic kidney disease (Q61.2), currently on peritoneal dialysis (PD) daily. He reports abdominal pain at the PD catheter site, redness, and cloudy effluent. Likely peritonitis (T85.817A - infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter). Assessment: ESRD on PD (N18.6); Peritonitis due to PD catheter (T85.817A); Polycystic kidney disease (Q61.2). Plan: Initiate broad-spectrum empiric antibiotics via PD fluid, send PD fluid for culture and cell count, consult Nephrology for urgent evaluation. This is a high-complexity encounter requiring urgent diagnosis and treatment for a life-threatening complication.

Billing Focus: Specifying 'peritoneal dialysis' and detailing the complication (T85.817A) supports billing for PD-related services, hospital admissions, and urgent procedures. This level of detail helps justify higher E/M levels for managing acute complications in a patient with ESRD.

Document specific laboratory abnormalities and their clinical implications related to CKD Stage 5, such as severe anemia, hyperkalemia, or metabolic acidosis.

Example: Patient is a 60 y/o male with CKD Stage 5 (N18.5) due to chronic glomerulonephritis (N03.9), presenting with worsening fatigue and dyspnea. Labs reveal severe normocytic, normochromic anemia (D63.1 - anemia in chronic kidney disease) with Hgb 7.2 g/dL, requiring immediate intervention. Potassium is 6.5 mmol/L (E87.5 - hyperkalemia). Assessment: CKD Stage 5 (N18.5); Severe anemia of CKD (D63.1); Hyperkalemia (E87.5). Plan: Transfuse 2 units PRBCs, administer IV calcium gluconate and insulin/dextrose for hyperkalemia, consult Nephrology for consideration of urgent dialysis.

Billing Focus: Documenting specific complications like severe anemia (D63.1) and hyperkalemia (E87.5) as sequelae of CKD Stage 5 justifies treatments (blood transfusion, IV medications) and supports the medical necessity for higher intensity services, including potential hospital admission or emergent dialysis, leading to higher E/M coding.

Clearly state the patient's functional status and any impact on activities of daily living (ADLs) or quality of life due to CKD Stage 5 symptoms or treatment.

Example: Patient is a 78 y/o female with End-Stage Renal Disease (N18.6) managed by facility-based hemodialysis. She reports significant generalized weakness and lethargy post-dialysis, limiting her ability to perform ADLs, requiring assistance with bathing and meal preparation. She expresses profound fatigue impacting her quality of life. Assessment: ESRD on hemodialysis (N18.6) with severe functional impairment (R53.83 - other fatigue; R54 - senility, for functional decline). Plan: Evaluate adequacy of dialysis, consider nutritional consultation, explore palliative care options to improve quality of life.

Billing Focus: Documenting functional limitations and the impact on ADLs (e.g., severe fatigue R53.83, general decline R54) provides a holistic view of the patient's condition, contributing to the overall complexity of care. This may support higher E/M levels for comprehensive care planning and coordination, especially for patients requiring skilled nursing or home health services.

Relevant CPT Codes

Related Diagnoses

Hierarchy